Prestige Consumer Healthcare Inc. (PBH) Stock Overview
Explore Prestige Consumer Healthcare Inc.’s financial performance, market position, analyst ratings, and future outlook.
Prestige Consumer Healthcare Inc. (PBH)
Key Financials
Key Financials
Market Cap
2.4B
P/E Ratio
14.14
EPS (TTM)
$4.42
ROE
0.09%
PBH Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Prestige Consumer Healthcare Inc. (NYSE: PBH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Prestige Consumer Healthcare Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PBH on the NYSE shows an RSI of 50.18, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $40.59 for the NYSE listing.
Key metrics behind Prestige Consumer Healthcare Inc.'s NYSE-traded stock include a P/E ratio of 14.14 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PBH on the NYSE.